Emerging Drug Could Help Treat a Common Liver Disease
Stony Brook UniversityTreating a liver disease called NASH (non-alcoholic steatohepatitis) is difficult. Now scientists believe they have found a pharmacologic approach that may inhibit NASH, and thus stop deadly conditions that result from NASH.